Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us


Marine bacteria offer new weapon against melanoma

Date: Mar-14-2019
A recent paper outlines how marine bacteria have inspired an entirely new way of fighting melanoma. The authors hope that their findings might eventually lead to a more effective treatment.Marine bacteria may provide a new weapon against melanoma.

Skin cancer is by far the most common type of cancer. Melanoma accounts for just 1 percent of skin cancer cases.

However, melanoma causes the majority of skin cancer deaths, primarily because once it metastasizes, there are limited treatment options.

According to estimates, doctors will diagnose 96,480 new cases of melanoma in the United States this year, and there will be 7,230 related deaths.

Melanoma occurs most often in older adults, but it is also one of the most common cancers in younger people.

Over the last 50 years, melanoma rates have risen at a worryingly rapid pace. Although increased levels of screening account for some of this change, they do not tell the whole story.

As mortality rates are relatively high for melanoma, and the number of cases is increasing, finding a new way of attacking this type of cancer is urgent.

New avenues to explore

Relatively recently, a class of drugs called BRAF inhibitors has shown promise for the treatment of melanoma. However, close to 50 percent of people do not respond to these drugs, and those who do tend to become resistant within months, making the treatment ineffective.

The race is on to uncover a new way to fight melanoma. Recently, researchers from the University of California in San Diego and Universidade Federal de São Paulo and Universidade de São Paulo in Brazil have taken inspiration from an unusual source: marine bacteria. William Fenical, James J. La Clair, and Leticia Costa-Lotufo led the team of researchers, who published their most recent investigation in ACS Medicinal Chemistry Letters.

Their latest work follows on from a paper that they published in 2014. In this previous study, the researchers investigated a chemical called seriniquinone, which they isolated from rare marine bacteria of the genus Serinicoccus.

Melanoma: Keeping these molecules apart could stop cancer spread
New research may have identified a novel way to reduce the risk of melanoma metastasizing.
Read now

In the laboratory, seriniquinone selectively destroyed melanoma cells by inducing cell death. It achieved this by targeting a cancer-protective protein called dermcidin. This study was the first to identify a small molecule that could directly attack malignant cells.

Of course, finding a chemical that works against free-floating cancer cells in a test tube is a far cry from creating a drug that can successfully defeat cancer in a living person. As the authors write:

"The translation of [seriniquinone] into a chemotherapeutic agent is complex. It requires significant medicinal chemistry efforts to generate a large number of derivatives to improve its 'drug-like' properties."

Closer to a new drug

The researchers' recent work brings them closer to designing a usable drug. Specifically, they managed to identify the parts of the seriniquinone molecule that furnish it with its anticancer activity.

Next, they altered other parts of the molecule to make it water-soluble and easier to purify. Both of these properties are essential to make seriniquinone a functional drug.

Importantly, the alterations did not affect seriniquinone's anticancer activity. The authors write:

"Overall, these studies suggest that it is feasible to design melanoma-specific seriniquinone derivatives with drug-like properties."

Although this work has brought the team closer to developing a suitable drug, more work is necessary. The authors are committed to continuing along this path and are already working on ways to purify and improve the action of these seriniquinone derivatives.

They hope that, eventually, they can bring a powerful melanoma drug to market. Although there is much work ahead, identifying a new potential way of attacking melanoma is a significant breakthrough.

/*.mnt_dlb_foot_container { display:block; width: 728px; height: 90px; }*/
/*@media (min-width: 990px) { .mnt_dlb_foot_container { display: none; } }
@media (min-width:1148px) { .mnt_dlb_foot_container { display:block;} }*/

Related coverage
Suggested Reading-->

What to know about nodular melanoma
Nodular melanoma is the most aggressive form of skin cancer. In this article, we look at the symptoms, causes, risk factors, and treatments for nodular melanoma.

Read now

What you need to know about chemotherapy
Chemotherapy is a widespread and effective way of treating cancerous tissues in the body. Chemotherapy destroys cancer cells, but its side effects can be debilitating and hard to manage. Find out here all about chemotherapy and how it works and whether the positive results balance out with the negatives ones.

Read now

What are the symptoms of skin cancer?
Skin cancer is the most common cancer in the United States. People should check every month for signs of melanoma and other skin cancers. In this article, we take a close look at the types of skin cancer and the symptoms to look for. We also discuss risk factors and prevention.

Read now

Amelanotic melanoma: Symptoms, treatment, and prevention
Amelanotic melanoma is a type of skin cancer that causes a growth or mole without any melanin. The growth may be pink or red. Learn more.

Read now

Stage 4 melanoma: What you need to know
Melanoma is a type of cancer that affects the skin cells. If it has progressed to stage 4, this means it has spread beyond the skin to other organs, such as the liver, brain, or lungs. In this article, learn about survival rates, traditional treatments, and new treatment methods, such as targeted therapy drugs.

Read now

Courtesy: Medical News Today
Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.